Nanotechnology in the life sciences, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 14
Published: Jan. 1, 2024
Language: Английский
Nanotechnology in the life sciences, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 14
Published: Jan. 1, 2024
Language: Английский
ACS Synthetic Biology, Journal Year: 2024, Volume and Issue: 13(7), P. 1994 - 2007
Published: June 20, 2024
The advancement in nanotechnology has completely revolutionized various fields, including pharmaceutical sciences, and streamlined the potential therapeutic of many diseases that endanger human life. synthesis green nanoparticles by biological processes is an aspect newly emerging scientific field known as "green nanotechnology". Due to their safe, eco-friendly, nontoxic nature, tools are better suited produce between 1 100 nm. Nanoformulation different types been made possible using production techniques commercially feasible novel precursors, such seed extracts, algae, fungi, act potent reducing, capping, stabilizing agents. In addition this, biofunctionalization also broadened its horizon environmental remediation innovations wound healing, antimicrobial, anticancer, nano biosensing. However, major challenge pertaining agglomeration may alter surface topology, which can affect physiology, thereby contributing system toxicity. Therefore, a thorough grasp nanoparticle toxicity biocompatibility required harness applications therapeutics.
Language: Английский
Citations
16Hybrid Advances, Journal Year: 2024, Volume and Issue: unknown, P. 100359 - 100359
Published: Dec. 1, 2024
Language: Английский
Citations
8Next Nanotechnology, Journal Year: 2025, Volume and Issue: 7, P. 100157 - 100157
Published: Jan. 1, 2025
Language: Английский
Citations
0Medicinal Research Reviews, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 24, 2024
Abstract Triple negative breast cancer (TNBC) displays a notable challenge in clinical oncology due to its invasive nature which is attributed the absence of progesterone receptor (PR), estrogen (ER), and human epidermal growth factor (HER‐2). The heterogenous tumor microenvironment (TME) TNBC composed diverse constituents that intricately interact evade immune response facilitate progression metastasis. Based on molecular gene expression, classified into four subtypes: basal‐like (BL1 BL2), luminal androgen (LAR), immunomodulatory (IM), mesenchymal. an aggressive histological variant with adverse prognosis poor therapeutic response. lack most patients could be heterogeneity disease, highlighting need for more effective treatments reliable prognostic biomarkers. Targeting certain signaling pathways their components has emerged as promising strategy improving patient outcomes. In this review, we have summarized interactions among various dynamic TME discussed classification subtypes. Moreover, purpose review compile provide overview recent data about recently discovered novel biomarkers targeted therapeutics proven successful treating metastatic TNBC. emergence strategies such chemoimmunotherapy, chimeric antigen (CAR)‐T cells‐based immunotherapy, phytometabolites‐mediated natural therapy, photodynamic photothermal approaches made significant positive impact paved way interventions.
Language: Английский
Citations
2Nanotechnology in the life sciences, Journal Year: 2024, Volume and Issue: unknown, P. 59 - 105
Published: Jan. 1, 2024
Language: Английский
Citations
1Nanotechnology in the life sciences, Journal Year: 2024, Volume and Issue: unknown, P. 179 - 231
Published: Jan. 1, 2024
Language: Английский
Citations
1Nanotechnology in the life sciences, Journal Year: 2024, Volume and Issue: unknown, P. 369 - 408
Published: Jan. 1, 2024
Language: Английский
Citations
0Nanotechnology in the life sciences, Journal Year: 2024, Volume and Issue: unknown, P. 39 - 57
Published: Jan. 1, 2024
Language: Английский
Citations
0Nanotechnology in the life sciences, Journal Year: 2024, Volume and Issue: unknown, P. 133 - 147
Published: Jan. 1, 2024
Language: Английский
Citations
0Nanotechnology in the life sciences, Journal Year: 2024, Volume and Issue: unknown, P. 471 - 503
Published: Jan. 1, 2024
Language: Английский
Citations
0